Biocept Inc. buy stratec
Start price
26.03.19
/
50%
€300.36
Target price
04.11.21
€811.80
Performance (%)
-65.44%
End price
05.11.21
€103.80
Summary
This prediction ended on 05.11.21 with a price of €103.80. Massive losses of -65.44% were the result for the BUY prediction by stratec. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biocept Inc. | - | - | - | - |
| iShares Core DAX® | -0.197% | -1.724% | 12.342% | 55.750% |
| iShares Nasdaq 100 | -3.612% | -3.768% | 0.437% | 80.820% |
| iShares Nikkei 225® | 1.176% | 2.165% | 19.971% | 49.596% |
| iShares S&P 500 | -0.825% | -1.916% | 0.099% | 55.940% |
Comments by stratec for this prediction
In the thread Biocept Inc. diskutieren
stratec stimmt dem Sentiment von 'Buy' zu
Biocept’s Target Selector is a liquid biopsy platform which, in addition to providing actionable data based on circulating tumor DNA (ctDNA) analysis, incorporates circulating tumor cell (NYSE:CTC) analysis which differentiates the company in an increasingly ‘crowded’ liquid biopsy space.”
In the thread Trading Biocept Inc.
Die von stratec gewählte maximale Laufzeit wurde überschritten